Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: It seems to me that

Jan 16, 2007 10:00AM

Jan 16, 2007 10:20AM

Jan 16, 2007 11:32AM

Jan 16, 2007 11:41AM

Jan 16, 2007 11:51AM

Jan 16, 2007 11:58AM
i can argue with all the points u have made. when u are a young company trying to establish itself and u dump the treasury to appease the debt financier u send the wrong message. the dividend play would only have worked if we had a huge treasury or we knew we were expecting immediate replacement capital. with regards to the acquisition, talk is cheap. might we not be in a better position as a company if the treasury was not off loaded to its "sharehholders" in pursuit of that acquisition? i am not arguing that we have not experienced price appreciation from the lows but i am stating that the BOD has had nothing to do with this and their few decisions have not benefited the sharehholder....yet they granted themselves options. i would like the BOD to address what we are doing with the office space we rented? or is this again a well thought out move by the "shoes" on the BOD? please point out your favorite BOD decision that has benefited the share price? teremoto

Jan 16, 2007 12:14PM

Jan 16, 2007 12:18PM
Share
New Message
Please login to post a reply